Introduction {#S1}
============

Brucellosis is a zoonosis disease, well-documented cause of fever of unknown origin, with varied and nonspecific symptoms. Involvement of the central nervous system (CNS) is a rare occurrence in childhood and is present in less than 2% of cases, predominantly with B. Melitensis. The clinical presentation of brucellosis localized to CNS is diverse and localized forms are difficult to diagnose. There are a few reports concerning cranial nerves involvement.^[@R1],[@R2]^

The available literature on optic neuritis in childhood stems largely from case report or retrospective case series. Optic neuritis presents differently in children than in adults. It is considerable less common in children and most cases are due to an immune-mediated process following an antecedent viral illness.^[@R3]^ Optic neuritis has also been linked to acute infection with Epstein Barr Virus, Borrelia, measles, mumps and varicella. Less commonly, optic neuritis may be the first manifestation of multiple sclerosis. Optic neuritis linked to Brucella infection is rare and scarcely reported in literature. We report a case of childhood neurobrucellosis presenting as optic neuritis.

Case Report {#S2}
===========

A previously healthy 11 year old girl was admitted with headache, retroorbital pain and acute right eye visual impairment. She had no significant personal or family history, except for a vacation in Portuguese countryside and a consumption of unpasteurized dairy products. There wasn't any recent immunization or preceding infection. Physical examination revealed sub-febrile temperature (37.7°C), mild oedema of right tibiotarsic joint, afferent pupillary defect and a fundoscopy with optic disc swelling. Best corrected visual acuity was 20/30 (Snellen chart) in the right eye. Other ocular lesions weren't reported. Neurologic examination was normal. Initial diagnostic was a post-infectious optic neuritis so endovenous methylprednisolone (250 mg, 6/6h) was initiated. Investigations showed a Brucella serum agglutination titer of 1/640. A lumbar puncture disclosed a slight pleocytosis of the cerebrospinal fluid, with mature white blood cells, predominantly lymphocytes. PCR for Brucella in the CSF was negative and MRI scan was normal. Oligoclonal bands were not performed. Serum samples tested negative for mycoplasma, cytomegalovirus, Epstein Barr and toxoplasmosis. Rheumatological profile (rheumatoid factor, ANA, ANCA, C3, C4) was normal.

Antibiotic therapy with Doxycycline (200 mg/d) and Rifampicin (600 mg/d) was performed during 6 months. Complete reversal of the visual and systemic symptoms was observed, with a 12 month follow-up. A decrease in Brucella serum agglutination titer to 1/80 was observed. Audiologic studies were performed and were normal.

Discussion {#S3}
==========

A definitive diagnosis of Neurobrucellosis is not possible as cultures were negative, but we based our diagnostic in a history of ingesting untreated milk or milk products in an endemic country, exclusion of other clinically significant etiologies in this setting, a serum agglutination titer for Brucella greater than 1:160, abnormal cerebrospinal fluid findings suggesting CNS inflammation, and resolution of symptoms with appropriate treatment.

Neurobrucellosis has neither a typical clinical picture nor specific cerebrospinal fluid findings.^[@R4],[@R5]^ Brucella organisms are fastidious and difficult to isolate in blood and CFS cultures, so serological tests are important.^[@R6],[@R7]^

There are few reports in literature regarding optic neuritis as a manifestation of neurobrucellosis in children. In the literature reviewed we found 4 case reports that are presented in [Table 1](#T1){ref-type="table"}. Treatment of acute brucellosis in adults and children older than 8 years, World Health Organization (WHO) guidelines recommend rifampin (600--900 mg) and doxycycline (200 mg) daily for a minimum of 6 weeks. Duration of therapy is controverse. We have chosen a 6 month therapy, as we were concerned on the possibility of relapse, especially if treatment is short.^[@R8]^

Table 1Literature review for neurobrucellosis optic neuritis.StudiesTali *et al.*^[@R10]^Tonekaboni *et al.*^[@R5]^Karapinar *et al.*^[@R11]^Elrazak^[@R12]^Our caseAge gender8 year-old boy13 years-old boy15 years-old girl13 years-old girl11 years-old girlBrucella background and treatment receivedYes\
Streptomycin-tetracycline combination for 15 daysYes\
Rifampin +\
doxycycline for 2 months + streptomycin for 25 daysNoNoNoClinical manifestationDiplopia, gradual loss of vision, facial paraesthesiae, vertigo, headacheVisual impairment and unilateral hearing lossAcute bilateral blindnessAcute blindness of the left eyeHeadache, retroorbital pain and acute right eye visual impairmentAntibiotic treatmentRifampicin for 6 monthsDoxycycline + rifampin + trimethoprim-sulfamethoxazole + ciprofloxacin for 1 yearRifampicin + doxycycline for 3 months + streptomycin for 1 monthTetracycline for 2 months + streptomycin for 3 weeksDoxycycline + Rifampicin for 6 monthsCorticoid treatmentNoPrednisolone for 2 monthsMethyl prednisolone for 7 daysPrednisolone for 3 monthsMethyl prednisolone for 1 day + Prednisolone for 1 monthResolution of symptomsThe headache, diplopia, vertigo and paraesthesiae had resolved, but the scotoma persistedVisual acuity, but not hearing, improvedComplete recoverComplete recoverComplete recover

In conclusion, in the investigation of acute optic neuritis in endemic countries, as the Mediterranean and the Middle East ones, it is important the exclusion of this disease, as it is a treatable cause.^[@R9]^
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